Biotech CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB) August 4, 2026
Biotech Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) August 4, 2026
Biotech Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference August 4, 2026
Biotech Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs August 1, 2026
Biotech IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) July 31, 2026
Biotech Agios Reports Second Quarter 2026 Financial Results and Provides Business Update July 30, 2026